Sara Faouzi

560 total citations · 1 hit paper
11 papers, 341 citations indexed

About

Sara Faouzi is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Sara Faouzi has authored 11 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Sara Faouzi's work include Testicular diseases and treatments (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Sara Faouzi is often cited by papers focused on Testicular diseases and treatments (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Sara Faouzi collaborates with scholars based in France, China and United States. Sara Faouzi's co-authors include Shensi Shen, Caroline Robert, Stéphan Vagner, Giuseppina Claps, Virginie Quidville, Jean‐Yves Scoazec, Émilie Routier, Séverine Le Roy, Fabrice André and Gérard Pierron and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cell Reports.

In The Last Decade

Sara Faouzi

10 papers receiving 341 citations

Hit Papers

The multiple roles of LDH in cancer 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Faouzi France 4 209 127 82 42 41 11 341
Mohd Feroz Mohd Omar Singapore 6 210 1.0× 148 1.2× 93 1.1× 45 1.1× 23 0.6× 12 326
Michelle Samuel Chattaragada Italy 5 256 1.2× 160 1.3× 105 1.3× 48 1.1× 61 1.5× 7 379
Florence Giffard France 13 320 1.5× 173 1.4× 90 1.1× 54 1.3× 43 1.0× 23 454
Laura Ghisolfi United States 7 219 1.0× 115 0.9× 163 2.0× 37 0.9× 28 0.7× 10 356
Mesquita Rodrigues Portugal 6 251 1.2× 194 1.5× 115 1.4× 35 0.8× 31 0.8× 7 385
Grinu Mathew United States 10 263 1.3× 101 0.8× 97 1.2× 51 1.2× 41 1.0× 16 360
Efrat Flashner-Abramson Israel 10 230 1.1× 97 0.8× 150 1.8× 35 0.8× 73 1.8× 13 393
Jang-Hyun Choi South Korea 7 195 0.9× 91 0.7× 139 1.7× 47 1.1× 52 1.3× 9 334
Yunhao Wu China 10 327 1.6× 226 1.8× 97 1.2× 52 1.2× 55 1.3× 14 436
Jessica C. Walrath United States 7 137 0.7× 67 0.5× 86 1.0× 51 1.2× 37 0.9× 7 334

Countries citing papers authored by Sara Faouzi

Since Specialization
Citations

This map shows the geographic impact of Sara Faouzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Faouzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Faouzi more than expected).

Fields of papers citing papers by Sara Faouzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Faouzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Faouzi. The network helps show where Sara Faouzi may publish in the future.

Co-authorship network of co-authors of Sara Faouzi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Faouzi. A scholar is included among the top collaborators of Sara Faouzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Faouzi. Sara Faouzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Faouzi, Sara, Léonor Chaltiel, Clément Dumont, et al.. (2025). Treatment of poor-risk non seminomatous germ-cell tumors (NSGCT) adapted by tumor marker decline: A 7-year multicenter real-world experience.. Journal of Clinical Oncology. 43(16_suppl). 5034–5034.
2.
Li, Kaixiu, Sara Faouzi, Tianjian Lu, et al.. (2023). Spatial patterns of the cap-binding complex eIF4F in human melanoma cells. Computational and Structural Biotechnology Journal. 21. 1157–1168. 2 indexed citations
3.
Claps, Giuseppina, Sara Faouzi, Virginie Quidville, et al.. (2022). The multiple roles of LDH in cancer. Nature Reviews Clinical Oncology. 19(12). 749–762. 173 indexed citations breakdown →
4.
Faouzi, Sara, Olivier Bouché, François Bertucci, et al.. (2021). Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study. Targeted Oncology. 16(4). 485–492. 4 indexed citations
5.
Faouzi, Sara, Léonor Chaltiel, Clément Dumont, et al.. (2021). Adaptation of chemotherapy to the decline tumor markers in patients with poor prognosis nonseminomatous germ cell tumors:Real-world French experience.. Journal of Clinical Oncology. 39(6_suppl). 385–385. 1 indexed citations
6.
Shen, Shensi, Sara Faouzi, Sylvie Souquère, et al.. (2020). Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation. Cell Reports. 33(8). 108421–108421. 100 indexed citations
7.
Shen, Shensi, Sara Faouzi, Sylvie Souquère, et al.. (2020). Melanoma Persister Cells are Tolerant to BRAF/MEK Inhibitors Via ACOX1-Mediated Fatty Acid Oxidation. SSRN Electronic Journal. 3 indexed citations
8.
Faouzi, Sara, et al.. (2019). Tumeurs germinales de stade I. Bulletin du Cancer. 106(10). 887–895. 1 indexed citations
9.
Shen, Shensi, Sara Faouzi, Amandine Bastide, et al.. (2019). An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells. Nature Communications. 10(1). 5713–5713. 55 indexed citations
10.
Bretagne, Marie, et al.. (2017). Quels biomarqueurs d’avenir ? Le point de vue des internes en oncologie à l’issue du congrès de l’ESMO 2016. Bulletin du Cancer. 104(9). 744–751. 1 indexed citations
11.
Dewolf, Maxime, et al.. (2016). Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy. SPIRE - Sciences Po Institutional REpository. PA2822–PA2822. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026